Voyager Therapeutics's total assets for Q2 2025 were $322.10M, a decrease of -8.82% from the previous quarter. VYGR total liabilities were $78.16M for the fiscal quarter, a -2.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.